Management of Hyperkalemia
The management of hyperkalemia requires a stepwise approach based on severity, with immediate stabilization of cardiac membrane using calcium gluconate for severe cases, followed by shifting potassium into cells with insulin/glucose or beta-agonists, and ultimately removing excess potassium from the body using potassium binders or dialysis. 1
Assessment and Stratification
- Definition: Hyperkalemia is defined as serum potassium >5.0 or >5.5 mEq/L (mmol/L) 1
- Severity assessment based on ECG changes:
- 5.5-6.5 mmol/L: Peaked/tented T waves (early sign)
- 6.5-7.5 mmol/L: Prolonged PR interval, flattened P waves
- 7.0-8.0 mmol/L: Widened QRS, deep S waves
10 mmol/L: Sinusoidal pattern, VF, asystole, or PEA 1
Emergency Management of Severe Hyperkalemia
Cardiac membrane stabilization (immediate effect, does not lower K+):
- Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes
- Onset: 1-3 minutes; Duration: 30-60 minutes 1
Shift potassium into cells (temporary measure):
- Insulin with glucose: 10 units regular insulin IV with 50 mL of 25% dextrose
- Onset: 15-30 minutes; Duration: 1-2 hours
- Nebulized albuterol: 10-20 mg over 15 minutes
- Onset: 15-30 minutes; Duration: 2-4 hours
- Sodium bicarbonate: 50 mEq IV over 5 minutes (if metabolic acidosis present)
- Onset: 15-30 minutes; Duration: 1-2 hours 1
- Insulin with glucose: 10 units regular insulin IV with 50 mL of 25% dextrose
Remove potassium from body:
- Diuresis: furosemide 40-80 mg IV
- Dialysis: Most effective method for severe cases 1
Important Caveat
Sodium polystyrene sulfonate should NOT be used for emergency treatment of life-threatening hyperkalemia due to its delayed onset of action 2, 3.
Non-Emergency Management and Chronic Hyperkalemia
Potassium Binders
| Agent | Starting Dose | Onset | Key Considerations |
|---|---|---|---|
| Patiromer (Veltassa) | 8.4g once daily | 7 hours | Separate from other medications by 3 hours; no sodium content |
| Sodium zirconium cyclosilicate (Lokelma) | 5-10g once daily | 1 hour | Contains sodium (400mg per 5g); more rapid onset |
| Sodium polystyrene sulfonate | 15-30g 1-4 times daily | Variable | Avoid chronic use due to GI side effects; high sodium content |
- For acute hyperkalemia: 10g of a potassium binder three times daily for up to 48 hours
- For maintenance therapy: 5-10g once daily 1
- Newer agents (patiromer and sodium zirconium cyclosilicate) are preferred over sodium polystyrene sulfonate due to fewer gastrointestinal adverse effects 3
Medication Review and Adjustment
- Review and adjust medications that contribute to hyperkalemia 1, 4:
- ACE inhibitors/ARBs (consider dose reduction rather than discontinuation)
- Potassium-sparing diuretics
- NSAIDs
- Aldosterone antagonists
- Calcineurin inhibitors
- Heparin and derivatives
- Trimethoprim
- Beta-blockers
Dietary Modifications
- Restrict potassium intake to <40 mg/kg/day 1
- Limit high-potassium foods such as:
- Processed foods
- Bananas, oranges
- Potatoes, tomatoes
- Legumes
- Yogurt, chocolate 1
Special Considerations
Chronic Kidney Disease
- Hyperkalemia occurs in up to 73% of patients with advanced CKD 1, 5
- Consult nephrology for CKD stage 4 (eGFR <30 mL/min/1.73 m²) 1
- Consider potassium binders for long-term management 5
Heart Failure
- Hyperkalemia occurs in up to 40% of heart failure patients 1
- Benefits of ACEI/ARB therapy often outweigh risks; consider dose reduction rather than discontinuation 1
Monitoring
- Monitor potassium levels every 1-4 weeks, especially when changing therapy 1
- Watch for signs of hypomagnesemia (muscle cramps, arrhythmias, weakness) 1
- Monitor for gastrointestinal side effects from potassium binders 1
Pitfalls to Avoid
Don't rely on sodium polystyrene sulfonate for emergency treatment of life-threatening hyperkalemia due to its delayed onset of action 2
Don't discontinue beneficial medications like ACE inhibitors/ARBs without attempting dose reduction first 1
Don't overlook drug interactions that may worsen hyperkalemia, particularly NSAIDs in patients on ACEIs 1, 4
Don't forget to monitor for excessive diuresis, as volume depletion can worsen renal function and paradoxically increase hyperkalemia risk 1
Don't assume all dietary potassium sources have equal impact on serum potassium levels; focus on limiting the most problematic high-potassium foods 6